Published in Biotech Law Weekly, March 24th, 2006
The net sales of $80.3 million represented a 3% increase over net sales of $77.7 million during the fourth quarter of 2004. Excluding the impact of foreign currency, net sales increased 6% during the fourth quarter. Net income for the fourth quarter of 2005 totaled $2 million or 6 cents per diluted share.
For the full year 2005, the company's net sales totaled a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.